Evaluation Of The Efficacy and Safety Of Tri-ActiveTM In Treatment Of Cellulite

Clinical Study For Evaluation Of The Efficacy and Safety Of Tri-ActiveTM (Deka M.E.L.A., Itália) In Treatment Of Cellulite

The purpose of this study is to assess the efficacy of device TRI-ACTIVETM (DEKA M.E.L.A., Itália)in the treatment od cellulite and body contouring.

Study Overview

• Status: Terminated
• Conditions: Cellulite; Body Contouring
• Intervention / Treatment: Device: TRI-ACTIVE LASERDERMOLOGYTM (DEKA M.E.L.A., Itália)

Detailed Description

The present study is a clinical, opened trial and single-center.

The patients will be treated by six laser diodes, localised cooling system and rhythmical intake massage device. Application of the massage will be performed for 8 weeks in a total of 16 treatment sessions: twice a week.

A set of photographs will be taken at visit 1 (baseline), visit 2 and 3 with standardized positions and lighting conditions.

• Study Type: Interventional
• Enrollment: 20
• Phase: Phase 4

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 45 years (Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: Female

Description

Inclusion Criteria:

1. Written Informed Consent;
2. Subjects agreeing to take part of all procedures of the study (including mechanical massage, photographs), after being fully informed on the objectives and nature of the investigations;
3. Female subjects between 18-45 years;
4. Subjects presenting with cellulite grades I-III on buttocks and thighs;
5. Medical history and physical examination which, based on the investigator's opinion, do not prevent the patient from taking part in the study and use the device under investigation;
6. Female subjects of childbearing age should present a negative urine pregnancy test and should be using an effective contraceptive method (3 months before the enrollement untill the end of the study);
7. Body Mass Index (BMI = weight/height2) beetwen 20,0-25,0;
8. Availability of the subject throughout the duration of the study (60 days);
9. Availability of the subject in maintaining a stable weight during the study (variation less than 2 kg)
10. Subjects with sufficient schooling and awareness to enable them to cooperate to the degree required by this protocol.

Exclusion Criteria:

1. Pregnant women or women intending to become pregnant during the study (next 3 months);
2. BMI superior 25,0;
3. Subjects with diabetes mellitus, cardiac insufficiency, asthma, or bronchitis;
4. Subjects participating in other clinical trials;
5. Subjects with neoplastic disorders, uncontrolled thyroid disorders or uncontrolled hypertension;
6. Subjects with coagulation disorders, using anticoagulants or tendency of bruises;
7. Subjects with vascular disorders (phlebitis or varicose veins) in the area to be treated;
8. Any prior aesthetic surgery affecting the area to be treated (liposuction, Subcision®), 3 months before the study, that may interfere with results;
9. Any other prior anti-cellulite treatment or body measures treatment, 30 days prior to the study;
10. Subjects with inflammation or active infection in the area to be treated.
11. Subjects with a history of adverse effects, which in the investigator's opinion should prevent the patient from participating in the study;
12. Patients with cutaneous or vascular alterations, that difficult visualization and documentation of cellulite;
13. Subjects with a history of medical treatment non-adherence or showing unwillingness to adhere to the study protocol;
14. Subjects who can not come to the visits (one missing visit/ month is allowed);
15. Subjects intending to initiate any intensive sport;
16. Subjects using analgesics, non-hormonal antiinflammatories, antihistaminics, corticosteroids, or diuretics;
17. Subjects tanned, or intending to expose the area of study to sun, artificial UV, or self-tanning during the study;
18. Any condition that, in the opinion of the investigator, can compromise the evaluation of the study.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Non-Randomized
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Assessment of effectiveness of treatment based on current classification of cellulite and evaluation corporal measures

Secondary Outcome Measures

Outcome Measure
Safety analysis
Assessment of subject's satisfaction
Visual assessments of the treated area before and after treatment

Collaborators and Investigators

• Sponsor: Brazilan Center for Studies in Dermatology
• Investigators: Study Director: Doris Hexsel, Brazilian Center fpr Dermatological Studies

Study record dates

Study Major Dates

• Study Start: August 1, 2006
• Study Completion: November 1, 2006

Study Registration Dates

• First Submitted: November 14, 2006
• First Submitted That Met QC Criteria: November 14, 2006
• First Posted (Estimate): November 15, 2006

Study Record Updates

• Last Update Posted (Estimate): March 12, 2008
• Last Update Submitted That Met QC Criteria: March 11, 2008
• Last Verified: March 1, 2008

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Skin Manifestations; Cellulite
• Other Study ID Numbers: 02CBED0602